The FDA recently approved the first and only non-surgical treatment for reduction of submental fullness called Kybella (formerly known as ATX-101). It has been under development for more than nine years, and it is the subject of over 20 clinical studies involving more than 2,600 patients. Dr. Lupo was one of the investigators during the clinical trial, and she has been named a trainer for Kythera, the makers of Kybella.
An insight to destroying excess fat with Kybella® explained by Dr. Mary Lupo
What is KYBELLA®?
The active ingredient in KYBELLA® is deoxycholic acid. This acid is produced by the gallbladder.
It is produced by the gallbladder to emulsify fat for proper digestion.
How does KYBELLA® work?
Swelling and numbness are the common side effects to be prepared for when undergoing treatment.
This is a great non-surgical option for the permanent reduction of excess fat.
The active ingredient in KYBELLA® is deoxycholic acid. This acid is produced by the gallbladder.
It is produced by the gallbladder to emulsify fat for proper digestion.
How does KYBELLA® work?
- KYBELLA® is injected into the area of fat.
- The fat within the fat cells is immediately emulsified.
- The fat cells explode and are permanently destroyed.
Swelling and numbness are the common side effects to be prepared for when undergoing treatment.
This is a great non-surgical option for the permanent reduction of excess fat.
Kybella is a non-human and non-animal patented formulation of deoxycholic acid, a naturally-occurring molecule in the body that aids in the breakdown and absorption of dietary fat. When injected into subcutaneous fat, Kybella causes the destruction of fat cells, followed by a natural healing and elimination process to improve the chin profile. Once destroyed, those cells cannot store or accumulate fat. Patients who want to dramatically improve their jawline with non-surgical options can be treated with Kybella in conjunction with dermal fillers and/or radio-frequency and ultrasound devices for additional definition and skin tightening.
Kybella is administered by injections into the fat under the chin through a series of treatments spaced no less than one month apart. Many patients experienced visible results in two to four treatments, and up to six treatments may be administered depending on the desired outcome of the patient and treating physician. Once the aesthetic response is achieved, retreatment is not expected.
If you are interested in learning more about this treatment or to see if you are a candidate, please contact our office to schedule a consultation.
